BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 23754278)

  • 1. The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.
    Ghosh A; Saminathan H; Kanthasamy A; Anantharam V; Jin H; Sondarva G; Harischandra DS; Qian Z; Rana A; Kanthasamy AG
    J Biol Chem; 2013 Jul; 288(30):21955-71. PubMed ID: 23754278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of natural resistance-associated macrophage protein-1 (Nramp1) is associated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)/1-methyl-4-phenylpyridinium (MPP
    Wu KC; Liou HH; Lee CY; Lin CJ
    Neuropathol Appl Neurobiol; 2019 Feb; 45(2):157-173. PubMed ID: 29679389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resilin, an insect-derived elastomeric protein, protects dopaminergic neurons in Parkinson disease models.
    Lim HS; Park G
    Neurosci Lett; 2022 Jun; 781():136667. PubMed ID: 35490904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
    Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
    Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease.
    Stahl K; Rahmani S; Prydz A; Skauli N; MacAulay N; Mylonakou MN; Torp R; Skare Ø; Berg T; Leergaard TB; Paulsen RE; Ottersen OP; Amiry-Moghaddam M
    PLoS One; 2018; 13(3):e0194896. PubMed ID: 29566083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.
    Ding YX; Xia Y; Jiao XY; Duan L; Yu J; Wang X; Chen LW
    Neurochem Res; 2011 Oct; 36(10):1759-66. PubMed ID: 21562748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway.
    Jo MG; Ikram M; Jo MH; Yoo L; Chung KC; Nah SY; Hwang H; Rhim H; Kim MO
    Mol Neurobiol; 2019 Jan; 56(1):39-55. PubMed ID: 29675576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orexin B protects dopaminergic neurons from 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity associated with reduced extracellular signal-regulated kinase phosphorylation.
    Ma X; Cao F; Cui J; Li X; Yin Z; Wu Y; Wang Q
    Mol Biol Rep; 2024 May; 51(1):669. PubMed ID: 38787465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model.
    Seo MH; Yeo S
    Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson's disease.
    Hu YB; Zhang YF; Wang H; Ren RJ; Cui HL; Huang WY; Cheng Q; Chen HZ; Wang G
    Cell Death Dis; 2019 Aug; 10(8):589. PubMed ID: 31383850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEP-1-heat shock protein 27 protects from neuronal damage in cells and in a Parkinson's disease mouse model.
    Lee YP; Kim DW; Kang HW; Hwang JH; Jeong HJ; Sohn EJ; Kim MJ; Ahn EH; Shin MJ; Kim DS; Kang TC; Kwon OS; Cho SW; Park J; Eum WS; Choi SY
    FEBS J; 2012 Jun; 279(11):1929-42. PubMed ID: 22429328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
    Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
    J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.
    Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S
    Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease.
    Viswanath V; Wu Y; Boonplueang R; Chen S; Stevenson FF; Yantiri F; Yang L; Beal MF; Andersen JK
    J Neurosci; 2001 Dec; 21(24):9519-28. PubMed ID: 11739563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease.
    Ghosh A; Roy A; Matras J; Brahmachari S; Gendelman HE; Pahan K
    J Neurosci; 2009 Oct; 29(43):13543-56. PubMed ID: 19864567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene disruption of caspase-3 prevents MPTP-induced Parkinson's disease in mice.
    Yamada M; Kida K; Amutuhaire W; Ichinose F; Kaneki M
    Biochem Biophys Res Commun; 2010 Nov; 402(2):312-8. PubMed ID: 20937256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2',3'-Dideoxycytidine Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease.
    Niu J; Xiong J; Hu D; Zeng F; Nie S; Mao S; Wang T; Zhang Z; Zhang Z
    Neurochem Res; 2017 Oct; 42(10):2996-3004. PubMed ID: 28631231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.